Kestra Medical Technologies (KMTS) Cash Flow: Operating & Free Cash Flow

Kestra Medical Technologies Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Kestra Medical Technologies, Ltd. (KMTS) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021	FY 2019
Period ending	Apr 2026	Apr 2025	Apr 2024	Apr 2023	Apr 2021	Apr 2020
Operating Activities
Net Income	-131.61	-113.81	-94.12	-94.12	-34.10	-29.47
Depreciation & Amortization	8.71	7.97	11.56	4.86	0.42	0.48
Deferred Income Tax	0.17	0.06	0.01	-0.05	0.00	0.00
Stock Based Compensation	33.64	24.27	1.49	1.21	1.86	0.70
Change in Working Capital	1.78	-6.20	3.89	1.30	-0.02	-2.01
Change in Accounts Receivable	-9.06	-8.78	-2.00	-2.50	0.00	0.00
Change in Inventory	-0.46	-3.44	-1.18	-0.73	0.00	0.00
Change in Accounts Payable	4.30	2.84	7.34	2.14	-0.13	-0.79
Change in Other Working Capital	2.20	3.18	2.44	6.72	-2.00	-0.45
Other Operating Activities	2.20	10.11	2.44	6.72	1.94	0.00
Net Cash from Operating Activities	-81.70	-77.61	-72.24	-69.64	-29.90	-30.29
Investing Activities
Capital Expenditures	-35.42	-23.59	-12.51	-15.46	-0.34	-0.23
Purchases of Investments	-168.04	0.00	0.00	0.00	0.00	0.00
Other Investing Activities	-0.34	0.28	0.29	0.00	0.00	0.00
Net Cash from Investing Activities	-203.28	-23.31	-12.23	-15.46	-0.33	-0.23
Financing Activities
Debt Repayment	0.00	0.00	-39.12	-5.33	20.00	0.00
Common Stock Issued	149.29	215.79	0.00	0.00	30.33	30.42
Dividends Paid	-0.32	-1.65	-0.80	-0.67	-0.19	-0.18
Other Financing Activities	-2.47	116.13	-2.35	-0.67	-1.52	-0.18
Net Cash from Financing Activities	147.10	330.26	77.73	96.11	48.82	30.24
Summary
Net Change in Cash	-137.89	229.35	-6.74	11.00	18.59	-0.29
Cash at Beginning of Period	237.93	8.58	15.32	4.32	6.27	6.55
Cash at End of Period	100.04	237.93	8.58	15.32	24.85	6.27
Free Cash Flow	-117.12	-101.20	-84.75	-69.64	-30.23	-30.53
Supplemental Disclosures
Interest Paid	-	4.85	3.63	-	-	-
Income Taxes Paid	-	0.08	-0.03	0.01	0.21	-

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Kestra Medical Technologies Cash Flow

What is Kestra Medical Technologies's free cash flow?

Kestra Medical Technologies had negative free cash flow of $117.12M in fiscal 2026 (fiscal year ended Apr 30, 2026), operating cash flow of −$81.70M minus $35.42M of capital expenditures.

How much does Kestra Medical Technologies spend on capital expenditures?

Kestra Medical Technologies spent $35.42M on capital expenditures in fiscal 2026, compared with $23.59M a year earlier.

Does Kestra Medical Technologies pay dividends or buy back shares?

Yes. In fiscal 2026 Kestra Medical Technologies returned $323.00K in dividends to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition